文献速递神经肿瘤

术前放疗在临床前胶质母细胞瘤模型中的效果:一种范式转变方法

Effects of PreOperative radiotherapy in a preclinical glioblastoma model: a paradigm-shift approach.
PubMed 文献 · J Neurooncol · 2024-07-22

在颅内胶质母细胞瘤大鼠模型中,于肿瘤切除前2周或切除后给予30 Gy分五次低分次放疗,术前放疗组中位生存期显著高于术后放疗组(p<0.05),并显示复发肿瘤中巨噬细胞/小胶质细胞募集更低(p<0.01);作者认为这是首个在哺乳动物模型中显示胶质母细胞瘤切除前新辅助放疗可行且总生存更长的临床前研究,需进一步研究和试验确认。

要点

  • 术前放疗组中位生存期显著高于术后放疗组(p<0.05)。
  • 术前放疗组复发肿瘤中巨噬细胞/小胶质细胞募集低于术后放疗组(p<0.01)。
  • 作者认为这是首个在哺乳动物模型中显示胶质母细胞瘤切除前新辅助放疗可行且总生存更长的临床前研究。

核心结论

  • 作者认为这是首个在哺乳动物模型中显示胶质母细胞瘤切除前新辅助放疗可行且总生存更长的临床前研究,提示新的临床放疗策略具有强优越性。
  • 作者指出需进一步研究和试验以确认上述结果。

研究设计与样本

  • 临床前研究:对大鼠脑部在颅内胶质母细胞瘤切除前2周或切除后给予30 Gy分五次低分次局部放疗,以Kaplan-Meier分析确定生存。
  • 对切除和复发啮齿类肿瘤进行苏木精-伊红染色并测量细胞核大小和p21衰老标志物,用免疫组化评估小胶质细胞/巨噬细胞标志物,用RNAseq分析复发肿瘤基因表达变化。
  • 对来自正在进行的I/IIa期试验的两例人类患者进行Akoya多重染色作为原理验证。

主要发现

  • 术前放疗组中位生存期显著高于术后放疗组(p<0.05)。
  • 放疗使术前放疗组切除肿瘤的细胞质和细胞核增大(p<0.001),并在术后放疗组复发肿瘤中诱导衰老(p<0.05)。
  • 基因集富集分析(GSEA)提示术前放疗组增殖特征更强。
  • 术前放疗组复发肿瘤中巨噬细胞/小胶质细胞募集低于术后放疗组(p<0.01)。
  • Akoya多重染色结果提示术后放疗组肿瘤相关巨噬细胞(TAMs)细胞质中TGF-ß蓄积及CD4+淋巴细胞占优势。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需进一步研究和试验以确认上述结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: PreOperative radiotherapy (RT) is commonly used in the treatment of brain metastasis and different cancer types but has never been used in primary glioblastoma (GBM). Here, we aim to establish, describe, and validate the use of PreOperative RT for the treatment of GBM in a preclinical model. METHODS: Rat brains were locally irradiated with 30-Gy, hypofractionated in five doses 2 weeks before or after the resection of intracranial GBM. Kaplan-Meier analysis determined survival. Hematoxylin-eosin staining was performed, and nuclei size and p21 senescence marker were measured in both resected and recurrent rodent tumors. Immunohistochemistry assessed microglia/macrophage markers, and RNAseq analyzed gene expression changes in recurrent tumors. Akoya Multiplex Staining on two human patients from our ongoing Phase I/IIa trial served as proof of principle. RESULTS: PreOperative RT group median survival was significantly higher than PostOperative RT (p < 0.05). Radiation enlarged cytoplasm and nuclei in PreOperative RT resected tumors (p < 0.001) and induced senescence in PostOperative RT recurrent tumors (p < 0.05). Gene Set Enrichment Analysis (GSEA) suggested a more proliferative profile in PreOperative RT group. PreOperative RT showed lower macrophage/microglia recruitment in recurrent tumors (p < 0.01) compared to PostOperative RT. Akoya Multiplex results indicated TGF-ß accumulation in the cytoplasm of TAMs and CD4 + lymphocyte predominance in PostOperative group. CONCLUSIONS: This is the first preclinical study showing feasibility and longer overall survival using neoadjuvant radiotherapy before GBM resection in a mammalian model. This suggests strong superiority for new clinical radiation strategies. Further studies and trials are required to confirm our results.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Fernandez-Gil BI, Schiapparelli P, Navarro-Garcia de Llano JP, et al. Effects of PreOperative radiotherapy in a preclinical glioblastoma model: a paradigm-shift approach. J Neurooncol. 2024. PMID: 39037687. doi:10.1007/s11060-024-04765-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。